High-Throughput Antibody Screening Service

The traditional methods of antibody screening mainly depend on hybridoma screening, phage/yeast library screening and single cell screening. These processes are often time-consuming and inefficient.

 

Kinase Insight using antibody drug screening platform combines proteomics with mass spectrometry, NGS sequencing, and bioinformatics algorithms to rapidly and efficiently screen for antibodies with high affinity and strong developability. Furthermore, based on this platform, we utilize our unique big data and artificial intelligence algorithms to design more optimized lead molecules for subsequent drug development.